公开(公告)号：DK0592478T3

公开(公告)日：1999-08-30

申请号：DK92912628

申请日：1992-06-23

Applicant: BASF AG

Inventor： BRAATZ REINHARD ,  KURTH ROLAND ,  MENKEL-CONEN ELKE ,  RETTENMAIER HANSJOERG ,  FRIEDRICH THOMAS ,  SUBKOWSKI THOMAS

IPC: A61K38/46 ,  A61K38/00 ,  A61P1/00 ,  A61P1/14 ,  C12N1/20 ,  C12N9/20 ,  C12R1/38 ,  G01N33/573 ,  A61K37/54

Abstract: PCT No. PCT/EP92/01412 Sec. 371 Date Dec. 28, 1993 Sec. 102(e) Date Dec. 28, 1993 PCT Filed Jun. 23, 1992 PCT Pub. No. WO93/00924 PCT Pub. Date Jan. 21, 1993.The use of bacterial lipases which show an immunological cross-reaction with the antibodies to the lipase produced by the microorganism Pseudomonas spec. DSM 6483 and/or Pseudomonas cepacia IAM 1057 for producing drugs for the therapy of maldigestion is described.

公开(公告)号：ES2125901T3

公开(公告)日：1999-03-16

申请号：ES92912628

申请日：1992-06-23

Applicant: BASF AG

Inventor： BRAATZ REINHARD ,  KURTH ROLAND ,  MENKEL-CONEN ELKE ,  RETTENMAIER HANSJOERG ,  FRIEDRICH THOMAS ,  SUBKOWSKI THOMAS

IPC: A61K38/46 ,  A61K38/00 ,  A61P1/00 ,  A61P1/14 ,  C12N1/20 ,  C12N9/20 ,  C12R1/38 ,  G01N33/573

Abstract: PCT No. PCT/EP92/01412 Sec. 371 Date Dec. 28, 1993 Sec. 102(e) Date Dec. 28, 1993 PCT Filed Jun. 23, 1992 PCT Pub. No. WO93/00924 PCT Pub. Date Jan. 21, 1993.The use of bacterial lipases which show an immunological cross-reaction with the antibodies to the lipase produced by the microorganism Pseudomonas spec. DSM 6483 and/or Pseudomonas cepacia IAM 1057 for producing drugs for the therapy of maldigestion is described.

公开(公告)号：DE59209604D1

公开(公告)日：1999-02-11

申请号：DE59209604

申请日：1992-06-23

Applicant: BASF AG

Inventor： BRAATZ REINHARD ,  KURTH ROLAND ,  MENKEL-CONEN ELKE ,  RETTENMAIER HANSJOERG ,  FRIEDRICH THOMAS ,  SUBKOWSKI THOMAS

IPC: A61K38/46 ,  A61K38/00 ,  A61P1/00 ,  A61P1/14 ,  C12N1/20 ,  C12N9/20 ,  C12R1/38 ,  G01N33/573

Abstract: PCT No. PCT/EP92/01412 Sec. 371 Date Dec. 28, 1993 Sec. 102(e) Date Dec. 28, 1993 PCT Filed Jun. 23, 1992 PCT Pub. No. WO93/00924 PCT Pub. Date Jan. 21, 1993.The use of bacterial lipases which show an immunological cross-reaction with the antibodies to the lipase produced by the microorganism Pseudomonas spec. DSM 6483 and/or Pseudomonas cepacia IAM 1057 for producing drugs for the therapy of maldigestion is described.

公开(公告)号：CA2110497C

公开(公告)日：2005-04-19

申请号：CA2110497

申请日：1992-06-23

Applicant: BASF AG

Inventor： BRAATZ REINHARD ,  KURTH ROLAND ,  MENKEL-CONEN ELKE ,  RETTENMAIER HANSJOERG ,  FRIEDRICH THOMAS ,  SUBKOWSKI THOMAS

IPC: A61K38/46 ,  A61K38/00 ,  A61P1/00 ,  A61P1/14 ,  C12N1/20 ,  C12N9/20 ,  C12R1/38 ,  G01N33/573

Abstract: Described is the use of a bacterial lipase from Chromobacter viscosum, Pseudomonas cepacia IAM 1057, Pseudomonas fluorescens and Pseudomonas DSM 6535 which shows a positive immunological cross-section to antibodies of the lipase from Pseudomonas spec. DSM 6483. The lipase from Pseudomonas spec. DSM 6535 is used to produce drugs for use in therapy of maldigestion. The lipase is formed from the species Psedomonas spec. DSM 6483 and/or Pseudonomas cepacia IAM 1057.

公开(公告)号：AT175117T

公开(公告)日：1999-01-15

申请号：AT92912628

申请日：1992-06-23

Applicant: BASF AG

Inventor： BRAATZ REINHARD ,  KURTH ROLAND ,  MENKEL-CONEN ELKE ,  RETTENMAIER HANSJOERG ,  FRIEDRICH THOMAS ,  SUBKOWSKI THOMAS

IPC: A61K38/46 ,  A61K38/00 ,  A61P1/00 ,  A61P1/14 ,  C12N1/20 ,  C12N9/20 ,  C12R1/38 ,  G01N33/573

Abstract: PCT No. PCT/EP92/01412 Sec. 371 Date Dec. 28, 1993 Sec. 102(e) Date Dec. 28, 1993 PCT Filed Jun. 23, 1992 PCT Pub. No. WO93/00924 PCT Pub. Date Jan. 21, 1993.The use of bacterial lipases which show an immunological cross-reaction with the antibodies to the lipase produced by the microorganism Pseudomonas spec. DSM 6483 and/or Pseudomonas cepacia IAM 1057 for producing drugs for the therapy of maldigestion is described.

公开(公告)号：CA2110497A1

公开(公告)日：1993-01-21

申请号：CA2110497

申请日：1992-06-23

Applicant: BASF AG

Inventor： BRAATZ REINHARD ,  KURTH ROLAND ,  MENKEL-CONEN ELKE ,  RETTENMAIER HANSJOERG ,  FRIEDRICH THOMAS ,  SUBKOWSKI THOMAS

IPC: A61K38/46 ,  A61K38/00 ,  A61P1/00 ,  A61P1/14 ,  C12N1/20 ,  C12N9/20 ,  C12R1/38 ,  G01N33/573

Abstract: 2110497 9300924 PCTABS00019 Described is the use of a bacterial lipase which shows a positive immunological cross-reaction to antibodies of the lipase to produce drugs for use in the therapy of digestive disorders. The lipase is formed from the species Psedomonas spec. DSM 6483 and/or Pseudomonas cepacia IAM 1057.